Inhaled formaldehyde: Evaluation of sensory irritation in relation to carcinogenicity

被引:103
作者
Arts, JHE [1 ]
Rennen, MAJ [1 ]
de Heer, C [1 ]
机构
[1] TNO Qual Life, NL-3700 AJ Zeist, Netherlands
关键词
formaldehyde; sensory irritation; carcinogenicity; benchmark dose;
D O I
10.1016/j.yrtph.2005.11.006
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Objectives: The critical health effects of formaldehyde exposure include sensory irritation and the potential to induce tumours in the upper respiratory tract. In literature, a concentration as low as 0.24 ppm has been reported to be irritating to the respiratory tract in humans. Nasal tumour-inducing levels in experimental animals seem to be 1-2 orders of magnitude larger. In this paper, the subjectively measured sensory irritation threshold levels in humans are discussed in line with findings obtained in animal experiments. In addition, a Benchmark dose (BMD) analysis of sensory irritation was used to estimate response incidences at different formaldehyde concentrations. Methods: Data on respiratory irritation and carcinogenicity of formaldehyde were retrieved from public literature and discussed. BMD analysis was carried out on human volunteer studies using the US-EPA BMD software. Results: Subjective measures of irritation were the major data found in humans to examine sensory (eye and nasal) irritation; only one study reported objectively measured eye irritation. On a normalized scale, mild/slight eye irritation was observed at levels >, 1 ppm, and mild/slight respiratory tract irritation at levels >= 2 ppm. With the BMD software, it was estimated that at a level of >= 1 ppm, only 9.5% of healthy volunteers experience 'moderate' (i.e., annoying) eye irritation (95% upper confidence limit). An important factor modulating the reported levels of irritation and health symptoms most probably includes the perception of odour intensity. In several studies, the 0-ppm control condition was missing. From the results of the long-term inhalation toxicity studies in experimental animals, a level of 1 ppm formaldehyde has been considered a NOAEL for nasal injury. Conclusions: Sensory irritation is first observed at levels of 1 ppm and higher. From both human and animal studies, it was concluded that at airborne levels for which the prevalence of sensory irritation is minimal both in incidence and degree (i.e., < 1 ppm), risks of respiratory tract cancer are considered to be negligibly low. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 160
页数:17
相关论文
共 71 条
  • [1] FORMALDEHYDE EXPOSURE, ACUTE PULMONARY RESPONSE, AND EXPOSURE CONTROL OPTIONS IN A GROSS-ANATOMY LABORATORY
    AKBARKHANZADEH, F
    VAQUERANO, MU
    AKBARKHANZADEH, M
    BISESI, MS
    [J]. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1994, 26 (01) : 61 - 75
  • [2] SENSORY IRRITATION OF UPPER AIRWAYS BY AIRBORNE CHEMICALS
    ALARIE, Y
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1973, 24 (02) : 279 - 297
  • [3] ANDERSEN L, 1983, FORMALDEHYDE TOXICIT, P154
  • [4] [Anonymous], 1989, FORMALDEHYDE
  • [5] ONE-YEAR INHALATION TOXICITY STUDY OF FORMALDEHYDE IN MALE-RATS WITH A DAMAGED OR UNDAMAGED NASAL-MUCOSA
    APPELMAN, LM
    WOUTERSEN, RA
    ZWART, A
    FALKE, HE
    FERON, VJ
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 1988, 8 (02) : 85 - 90
  • [6] An analysis of human response to the irritancy of acetone vapors
    Arts, JHE
    Mojet, J
    van Gemert, LJ
    Emmen, HH
    Lammers, JHCM
    Marquart, J
    Woutersen, RA
    Feron, VJ
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 2002, 32 (01) : 43 - 66
  • [7] The use of noncancer endpoints as a basis for establishing a reference concentration for formaldehyde
    Bender, J
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2002, 35 (01) : 23 - 31
  • [8] BENDER JR, 1983, AM IND HYG ASSOC J, V44, P463, DOI 10.1080/15298668391405139
  • [9] EXPERIMENTAL TOXICOLOGY OF FORMALDEHYDE
    BOLT, HM
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1987, 113 (04) : 305 - 309
  • [10] EVALUATION OF THE SENSORY IRRITATION TEST FOR THE ASSESSMENT OF OCCUPATIONAL-HEALTH RISK
    BOS, PMJ
    ZWART, A
    REUZEL, PGJ
    BRAGT, PC
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1992, 21 (06) : 423 - 450